Insulet PODD Net debt / EBITDA

Net debt / EBITDA at other companies

Eli LillyLLY

1.3×-0.7×

MedtronicMDT

2.9×-0.2×

Embecta Corp.EMBC

3.8×-2.7×

Opko HealthOPK

1.2×—

AbbottABT

2.5×+1.9×

InfuSystem HoldingsINFU

0.8×-0.7×

FAQ

What is Insulet's net debt / EBITDA?

Insulet (PODD) reported net debt / EBITDA of 0.7× in Q2 2026.

How has Insulet's net debt / EBITDA changed year-over-year?

Insulet's net debt / EBITDA decreased by 52.2% year-over-year, from 1.5× to 0.7×.

What is the long-term trend for Insulet's net debt / EBITDA?

Over 4 years (2021 to 2025), Insulet's net debt / EBITDA has grown at a -32.7% compound annual growth rate (CAGR), from 2.6× to 0.5×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.